In this study, we found that TGFβ significantly promotes the self-renewal activity of cancer stem cells in TNBC and that blocking TGFβ type I receptor kinase activity with a specific small-molecule inhibitor efficiently prevented these effects. This evidence concerns the gene TGFB1 and cancer.